Precise Biometrics AB (publ) (STO:PREC), is not the largest company out there, but it saw a double-digit share price rise of over 10% in the past couple of months on the OM. Less-covered, small caps sees more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Today I will analyse the most recent data on Precise Biometrics’s outlook and valuation to see if the opportunity still exists.
Check out our latest analysis for Precise Biometrics
What's the opportunity in Precise Biometrics?
Precise Biometrics is currently expensive based on my price multiple model, where I look at the company's price-to-earnings ratio in comparison to the industry average. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that Precise Biometrics’s ratio of 40.84x is above its peer average of 34.44x, which suggests the stock is trading at a higher price compared to the Electronic industry. Furthermore, Precise Biometrics’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach levels around its industry peers, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.
Can we expect growth from Precise Biometrics?
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 37% over the next couple of years, the future seems bright for Precise Biometrics. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
What this means for you:
Are you a shareholder? PREC’s optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. However, this brings up another question – is now the right time to sell? If you believe PREC should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.
Are you a potential investor? If you’ve been keeping tabs on PREC for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the positive outlook is encouraging for PREC, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.
If you'd like to know more about Precise Biometrics as a business, it's important to be aware of any risks it's facing. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of Precise Biometrics.
If you are no longer interested in Precise Biometrics, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
If you’re looking to trade Precise Biometrics, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
About OM:PREC
Precise Biometrics
Operates in the field of cybersecurity and biometric solutions in Sweden, Taiwan, China, the United States, and internationally.
Flawless balance sheet and slightly overvalued.
Market Insights
Weekly Picks

When GPS fails: this small cap is fixing a $54B drone problem

Why Amdocs is a high conviction Buy for me?
Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend
Recently Updated Narratives

Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform

MercadoLibre and the Spreadsheet Trick That Decides Everything
Diagnostyka SA: Solidny lider, który już nie jest tani
Popular Narratives

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
A wonderful business at reasonable price.

Warren Buffett Just Bet $10 Billion on Google. The Catch? You May Already Be Too Late.
Trending Discussion
As someone who has dealt directly with them as a CTO for a credit union, I have 8 years of horror stories about doing business with them. If there was any other competitor than could deliver 80% of Fiserv services, there would be a mad rush to migrate to them. They should thank their lucky stars they are a near monopoly. this industry is so ripe for a well funded competitor. Their integration of technology is awful, their ability to fix their own implementation screwups is sadly tragic. Sometimes they just silently kill support tickets without resolution and you never find out until you do a follow up inquiry. Why, because sometimes no one you are dealing with knows how to fix it and knows no one to ask for help. They can not meet their own implementation deadlines and sometimes there is no one on a technical team dealing with you that has any banking or credit union experience. The is an industry insider phrase when you meet other Fiserv customers called being "Fiserved". It means telling others of your worst stories of dealing with them. Ask around, all CTO's have some doozies.


